Aspiration Pneumonia

Overview

Aspiration pneumonia is an acute pulmonary infection caused by inhalation of bacteria-rich oropharyngeal or upper gastrointestinal material into the lower respiratory tract. It occurs when aspiration is combined with impaired airway protection, ineffective clearance and sufficient pathogenic bacterial burden. It is particularly important in older adults, people with neurological disease, frailty, dysphagia or reduced consciousness.

Aspiration pneumonia must be distinguished from aspiration pneumonitis, a sterile chemical lung injury that usually follows macroaspiration of gastric contents. The two syndromes can overlap and may be difficult to separate at first presentation, but the distinction matters because uncomplicated chemical pneumonitis does not require routine antibiotics.

Severe disease may cause acute hypoxaemic respiratory failure, sepsis, lung abscess or empyema. Immediate priorities are stabilisation, assessment of pneumonia severity and identification of any ongoing aspiration risk.

Anatomy & Physiology

Safe swallowing requires coordinated oral, pharyngeal and oesophageal phases. During the pharyngeal phase, elevation of the larynx, closure of the vocal cords and epiglottic movement protect the airway while the upper oesophageal sphincter relaxes. Sensation within the pharynx and larynx triggers swallowing and cough when material approaches or enters the airway.

Small-volume aspiration occurs even in healthy adults, particularly during sleep. Pneumonia is usually prevented by intact consciousness, glottic closure, an effective cough, mucociliary clearance, immune defence and a relatively low burden of pathogenic oral organisms.

Gravity influences where aspirated material settles. In a supine patient, the posterior upper-lobe segments and superior lower-lobe segments are commonly affected. In an upright patient, the basal lower lobes—often the right—are more exposed. Distribution is not perfectly specific and depends on body position during aspiration.

Aetiology & Risk Factors

Aetiology

Aspiration pneumonia usually follows aspiration of colonised oral or pharyngeal secretions. The microbiology resembles other community- or healthcare-associated pneumonias more closely than the historically assumed purely anaerobic infection. The likely pathogens depend on where the pneumonia was acquired, recent healthcare exposure, prior antimicrobial therapy and individual risk factors for resistant organisms.

Less commonly, aspiration of infected gastric contents may occur in the presence of gastric bacterial colonisation, intestinal obstruction or enteral feeding. Repeated aspiration may produce recurrent pneumonia or contribute to chronic suppurative airway disease.

Risk Factors

Risk is highest when impaired swallowing or airway protection is combined with poor oral health and reduced physiological reserve.

• Oropharyngeal dysphagia: stroke, Parkinson disease, dementia, motor neurone disease, multiple sclerosis, cerebral palsy or other neuromuscular disease
• Reduced consciousness: alcohol, sedatives, opioids, seizures, anaesthesia, head injury, metabolic encephalopathy or critical illness
• Impaired cough or airway clearance: frailty, immobility, respiratory muscle weakness, tracheostomy or chronic lung disease
• Structural or treatment-related swallowing impairment: head and neck cancer, radiotherapy, oesophageal disease, recent intubation or upper gastrointestinal surgery
• Poor oral health: dental caries, periodontal disease, xerostomia and dependence on others for oral care
• Feeding-related factors: dependence for feeding, rushed feeding, inappropriate positioning or poorly fitted dentures
• Gastro-oesophageal factors: reflux, vomiting, gastroparesis or bowel obstruction
• General vulnerability: advanced age, malnutrition, dehydration, immunosuppression and multimorbidity

Enteral feeding does not abolish aspiration risk. Patients may still aspirate oral secretions or refluxed gastric contents, and feeding tubes should not be regarded as automatic protection against pneumonia.^1,2

Pathophysiology

Aspiration delivers bacteria and inflammatory material beyond the larynx. Whether pneumonia develops depends on the volume and composition of the aspirate, bacterial burden, site of deposition and the patient’s cough, mucociliary and immune defences. Impaired clearance allows organisms to proliferate, producing alveolar inflammation, consolidation and ventilation–perfusion mismatch.

The inflammatory response causes fever, cough, sputum production, hypoxaemia and radiographic infiltrates. Severe infection may extend locally to cause necrosis, lung abscess or pleural infection, or systemically to cause sepsis and multiorgan dysfunction.

Aspiration pneumonitis follows a different initial mechanism: acidic or otherwise irritant gastric contents cause direct epithelial injury and an abrupt inflammatory response. Symptoms may begin within hours of a witnessed macroaspiration and can improve substantially with supportive care over the next 24–48 hours. Secondary bacterial infection can subsequently occur, particularly when clinical deterioration or failure to improve persists.

Clinical Manifestations

Presentation ranges from a typical acute pneumonia to a subtle decline in a frail older adult. A witnessed aspiration event is helpful but is not required.

Stroke, seizures and alcohol impair swallowing and airway protection, while vomiting increases aspiration risk

Features suggesting ongoing aspiration

• Recurrent pneumonia, particularly with dependent-lobe involvement
• Coughing, choking or breathlessness during eating or drinking
• Prolonged mealtimes, food pocketing or multiple swallows
• Wet or gurgling voice after swallowing
• Unexplained weight loss, dehydration or recurrent low-grade fever
• New swallowing difficulty after stroke, intubation or neurological deterioration

Aspiration pneumonitis more often presents with abrupt respiratory distress, hypoxaemia, bronchospasm and diffuse infiltrates shortly after a clear macroaspiration. Aspiration pneumonia more often evolves over hours to days with infective features, although substantial overlap limits certainty at presentation.

Diagnosis

Aspiration pneumonia is a clinical diagnosis supported by evidence of pneumonia together with aspiration risk or a compatible aspiration event. No single test confirms the diagnosis.

Initial assessment

• Measure oxygen saturation, respiratory rate, heart rate, blood pressure, temperature and conscious state.
• Assess sepsis and pneumonia severity using clinical judgement and a locally accepted tool such as CURB-65 where appropriate; frailty, comorbidity and baseline function may add important information not captured by a score.
• Obtain an arterial or venous blood gas when there is significant hypoxaemia, respiratory distress, altered consciousness or concern about ventilatory failure or lactate.

Focused investigations

• Chest radiograph: first-line imaging
  • Lower lobes, especially right
• Full blood count, urea, electrolytes and renal function: assess inflammatory response, dehydration, renal impairment and factors affecting antimicrobial choice or dosing.
• C-reactive protein
• Blood cultures: reserve for severe pneumonia, sepsis
• Sputum microscopy and culture: useful in severe disease, treatment failure, recurrent infection, bronchiectasis, recent healthcare exposure or risk of resistant pathogens; a poor-quality sample is difficult to interpret.

When to escalate imaging or procedures

• CT chest: use when the chest radiograph is inconclusive despite strong clinical concern, when an obstructing lesion or foreign body is possible, or when complications such as abscess, necrosis or empyema are suspected.
• Pleural ultrasound and diagnostic aspiration: perform when a clinically significant pleural effusion is present and pleural infection is possible.
• Bronchoscopy: not routine; consider for suspected foreign-body aspiration, airway obstruction, persistent lobar collapse or failure to respond despite appropriate therapy.

Swallowing assessment

Once the patient is stable, screen for dysphagia and refer to speech pathology when aspiration risk is suspected. A bedside assessment identifies risk and informs immediate feeding precautions, but it cannot reliably exclude silent aspiration. Instrumental assessment with videofluoroscopic swallow study or fibreoptic endoscopic evaluation of swallowing is appropriate when the mechanism remains uncertain or detailed information would alter rehabilitation and feeding decisions.¹

Feature	Aspiration pneumonia	Aspiration pneumonitis
Typical event	Often unwitnessed; recurrent microaspiration	Often witnessed macroaspiration of gastric contents
Onset	Evolves over hours to days	Abrupt, often within hours
Dominant features	Fever, purulent sputum, pneumonia syndrome	Hypoxaemia, bronchospasm, respiratory distress
Imaging	Dependent-segment infiltrate; focal or multifocal	Often bilateral or diffuse dependent infiltrates
Initial treatment	Antibiotics plus supportive care	Supportive care; antibiotics only if bacterial infection is suspected or emerges

Treatment

Initial management

• Oxygen if hypoxic
• Airway protection if necessary
• Suction/clear secretions
• IV fluids if septic/dehydrated
• Assess swallowing and aspiration risk

Antibiotics

For established aspiration pneumonia, choose antibiotics according to local guidelines and severity.

Common approaches include:

• Amoxicillin–clavulanate for community-acquired aspiration pneumonia
• Severe/hospital-acquired cases may require broader coverage depending on local resistance patterns.
• Anaerobic coverage is particularly considered when there is lung abscess or empyema, rather than being automatically required for every aspiration event.

Manage swallowing, nutrition and oral health

• Arrange speech pathology assessment and implement individualised swallowing strategies.

Aspiration pneumonitis

Provide supportive respiratory care after chemical aspiration. Antibiotics are not routinely indicated when the clinical picture is consistent with uncomplicated pneumonitis and the patient improves promptly. Reassess closely and initiate or continue antibiotics when bacterial pneumonia cannot be excluded, clinical deterioration occurs or improvement fails to emerge.

Complications & Prognosis

Complications

• Lung abscess
• Empyema
• Necrotising pneumonia
• Respiratory failure
• ARDS
• Bronchiectasis following recurrent aspiration
• Septic shock

Prognosis

Outcome is influenced by pneumonia severity, age, frailty, neurological disease, level of consciousness, nutritional status, comorbidity and whether the aspiration risk can be modified. Aspiration pneumonia generally carries a worse prognosis than non-aspiration community-acquired pneumonia because affected patients often have impaired swallowing, poor functional reserve and multiple comorbidities.^1,2

Clinical improvement should be evident within the first few days of appropriate treatment. Failure to improve should prompt review of the diagnosis, antimicrobial adequacy, resistant organisms, continued aspiration, airway obstruction and complications such as abscess or empyema.

Recurrent episodes warrant reassessment of swallowing, oral care, feeding support, medication burden and goals of care. In advanced neurodegenerative disease or severe frailty, management should include realistic discussion of prognosis, burdens of intervention and the patient’s preferences.¹

References

1. Simpson AJ, Allen JL, Chatwin M, Crawford H, Elverson J, Ewan V, et al. BTS clinical statement on aspiration pneumonia. Thorax. 2023;78(Suppl 1):s3–s21. doi:10.1136/thorax-2022-219699
2. Mandell LA, Niederman MS. Aspiration pneumonia. N Engl J Med. 2019;380(7):651–663. doi:10.1056/NEJMra1714562
3. Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, et al. Diagnosis and treatment of adults with community-acquired pneumonia: an official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200(7):e45–e67. doi:10.1164/rccm.201908-1581ST
4. Bai AD, Srivastava S, Digby GC, Girard V, Razak F, Verma AA. Anaerobic antibiotic coverage in aspiration pneumonia and the associated benefits and harms: a retrospective cohort study. Chest. 2024;166(1):39–48. doi:10.1016/j.chest.2024.02.025